2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation
; 142(25): e533-e557, 2020 12 22.
Article
em En
| MEDLINE
| ID: mdl-33215938
Palavras-chave
AHA Scientific Statements; atrial fibrillation; cardiovascular magnetic resonance; diastolic dysfunction; echocardiography; exercise stress testing; family screening; genetics; guidelines; hypertrophic cardiomyopathy; implantable cardioverter defibrillator; left ventricular outflow tract obstruction; occupation; physical activity; pregnancy; rhythm monitoring; risk stratification; sarcomeric genes; septal alcohol ablation; septal reduction therapy; shared decision-making; sudden cardiac death; surgical myectomy; systolic dysfunction; ventricular arrhythmias
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cardiomiopatia Hipertrófica
/
Cardiologia
/
Técnicas de Imagem Cardíaca
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Circulation
Ano de publicação:
2020
Tipo de documento:
Article